This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Feigenbaum, M. S. Articles by Pepine, C. J. Search for Related Content PubMed PubMed Citation Articles by Feigenbaum, M. S. Articles by Pepine, C. J.

CLINICAL STUDIES

Contracted plasma and blood volume in chronic heart failure

Matthew S. Feigenbaum, PhD , Michael A. Welsch, PhD , Matthew Mitchell, MS^* , Kevin Vincent, MS^* , Randy W. Braith, PhD^* and Carl J. Pepine, MD, MACC^*

^* Center for Exercise Science and Division of Cardiovascular Medicine, College of Health and Human Performance and College of Medicine, University of Florida, Gainesville, Florida, USA
Department of Health and Exercise Science, Furman University, Greenville, South Carolina, USA
Department of Kinesiology, Louisiana State University, Baton Rouge, Louisiana, USA

Manuscript received March 23, 1999; revised manuscript received July 29, 1999, accepted October 5, 1999.

Reprint requests and correspondence: Dr. Matthew S. Feigenbaum, Department of Health and Exercise Science, Furman University, Greenville, South Carolina 29613
Matt.Feigenbaum{at}Furman.edu

OBJECTIVES

The purpose of this study was to determine if long-term pharmacotherapy mediated changes in intravascular plasma and blood volumes in patients with chronic heart failure (CHF).

BACKGROUND

Intravascular fluid volume expansion is an acute compensatory adaptation to ventricular dysfunction in patients with CHF. To our knowledge there are no reports on plasma and blood volume measures in clinically stable patients with CHF receiving standard pharmacotherapy. Such information may provide a better understanding of the clinical hallmarks of heart failure.

METHODS

Plasma volume (PV) and blood volume (BV) were measured in 12 patients (62.8 ± 8.2 years old, 175.2 ± 6.8 cm, 96.2 ± 18.2 kg, peak oxygen consumption (·VO₂max) 15.2 ± 3.3 ml/kg per min) with CHF secondary to coronary artery disease (left ventricular ejection fraction 31.2 ± 9.7, New York Heart Association functional class 2.5 ± 0.5) and seven healthy subjects (71.7 ± 5.3 years old, 177.1 ± 10.8 cm, 84.4 ± 11.7 kg, ·VO₂max 26.0 ± 6.5 ml/kg per min) 3 to 4 h after eating and after supine rest using the Evan’s blue dye dilution technique. Venous blood samples were collected before blue dye infusion and analyzed for hematocrit (corrected 4% for trapped plasma and venous to whole body hematocrit ratio) and hemoglobin.

RESULTS

Hematocrit was 36.6 ± 3.5% and 37.4 ± 1.1%, and hemoglobin was 15.4 ± 1.9 and 16.2 ± 1.4 g/dl for patients with CHF and control subjects, respectively. Absolute PV was 3489.3 ± 655.0 and 3728.7 ± 813.2 ml, and absolute BV was 5,496.8 ± 1,025.4 and 5,942.4 ± 1,182.2 ml in patients with CHF and control subjects, respectively. Relative PV was 34.1 ± 12.9 versus 44.5 ± 9.0 ml/kg (p 0.05), and relative BV was 58.5 ± 12.3 versus 70.8 ± 12.6 ml/kg (p 0.05) in patients with CHF and control subjects, respectively.

CONCLUSIONS

Our data indicate significantly lower intravascular volumes in patients with CHF than in control subjects, indicating a deconditioned state or excessive diuresis, or both. The contracted PV and BV may contribute to exercise intolerance, shortness of breath and chronic fatigue, secondary to reduced cardiac output or regional blood flow, or both.

Abbreviations and Acronyms   ACE = angiotensin-converting enzyme   ANCOVA = analysis of covariance   BV = blood volume   CHF = chronic heart failure   PV = plasma volume   RPE = rating of perceived exertion   O2max = maximum oxygen consumption

This article has been cited by other articles:

				S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J. Am. Coll. Cardiol., April 14, 2009; 53(15): e1 - e90. [Full Text] [PDF]

				2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation, April 14, 2009; 119(14): e391 - e479. [Full Text] [PDF]

				P. R. Kalra, C. Anagnostopoulos, A. P. Bolger, A. J. S. Coats, and S. D. Anker The regulation and measurement of plasma volume in heart failure J. Am. Coll. Cardiol., June 19, 2002; 39(12): 1901 - 1908. [Abstract] [Full Text] [PDF]

				W. Wang, H. D. Schultz, and R. Ma Volume expansion potentiates cardiac sympathetic afferent reflex in dogs Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H576 - H581. [Abstract] [Full Text] [PDF]